NP
EXAS

NorthRock Partners’s Exact Sciences EXAS Stock Holding History

NorthRock Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,302
Closed -$291K – 809
2024
Q3 		$291K Buy
+4,302
New +$243K 0.01% 508
2024
Q2 		– Sell
-3,907
Closed -$270K – 823
2024
Q1 		$270K Buy
3,907
+343
+10% +$21.7K 0.01% 504
2023
Q4 		$264K Buy
+3,564
New +$234K 0.01% 484
2023
Q3 		– Sell
-2,415
Closed -$227K – 364
2023
Q2 		$227K Sell
2,415
-884
-27% -$69K 0.02% 267
2023
Q1 		$224K Buy
+3,299
New +$212K 0.02% 288
2022
Q2 		– Sell
-2,981
Closed -$208K – 319
2022
Q1 		$208K Buy
+2,981
New +$218K 0.02% 318

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NorthRock Partners's EXAS Position: Q4 2024 in Review

NorthRock Partners sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 4,302 shares — an estimated $291K sold.

NorthRock Partners first reported a position in EXAS in Q1 2022 and held it in 6 quarters. The position peaked at $291K in Q3 2024. 593 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • NorthRock Partners reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • NorthRock Partners sold 4,302 Exact Sciences shares in Q4 2024, an estimated $291K.
  • NorthRock Partners first reported a position in Exact Sciences in Q1 2022 and held it in 6 quarters.
  • NorthRock Partners's Exact Sciences position peaked at $291K in Q3 2024.
  • 593 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on NorthRock Partners's 13F filing for Q4 2024, filed 14 Feb 2025.